LYDIA WILBANKS: Open Payments
NPI 1811623440 · AURORA, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$440 in 19 payments from 11 companies in 2025. Trend: 2023 $1,981 · 2024 $2,510 · 2025 $440
Food & beverage: $440
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 4 | $99 |
| GENZYME CORPORATION | 3 | $88 |
| ABBVIE INC. | 2 | $41 |
| Organogenesis Inc. | 2 | $39 |
| UCB, Inc. | 2 | $37 |
| Regeneron Healthcare Solutions, Inc. | 1 | $36 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $34 |
| LEO Pharma Inc. | 1 | $21 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $17 |
| PFIZER INC. | 1 | $15 |
Products named: DUPIXENT, Sotyktu, Bimzelx, SPEVIGO, RINVOQ, NOVACHOR, ADBRY, ILUMYA.
Industry payments across CO — which companies pay providers there.
